Financial Sense Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,757
Closed -$201K 106
2022
Q1
$201K Buy
+2,757
New +$185K 0.08% 74

Other funds holding BMY

Financial Sense Advisors's BMY Position: Q2 2022 in Review

Financial Sense Advisors sold out of Bristol-Myers Squibb (BMY) in Q2 2022, closing a stake of 2,757 shares — an estimated $201K sold.

Financial Sense Advisors first reported a position in BMY in Q1 2022 and held it in 1 quarter. The position peaked at $201K in Q1 2022. 2,538 funds tracked by Wall St. Rank hold BMY as of Q2 2022.

  • Financial Sense Advisors reported no remaining Bristol-Myers Squibb position as of Q2 2022 after selling out during the quarter.
  • Financial Sense Advisors sold 2,757 Bristol-Myers Squibb shares in Q2 2022, an estimated $201K.
  • Financial Sense Advisors first reported a position in Bristol-Myers Squibb in Q1 2022 and held it in 1 quarter.
  • Financial Sense Advisors's Bristol-Myers Squibb position peaked at $201K in Q1 2022.
  • 2,538 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2022.

Based on Financial Sense Advisors's 13F filing for Q2 2022, filed 18 Jul 2022.